DE1415026U - - Google Patents

Info

Publication number
DE1415026U
DE1415026U DENDAT1415026D DE1415026DU DE1415026U DE 1415026 U DE1415026 U DE 1415026U DE NDAT1415026 D DENDAT1415026 D DE NDAT1415026D DE 1415026D U DE1415026D U DE 1415026DU DE 1415026 U DE1415026 U DE 1415026U
Authority
DE
Germany
Prior art keywords
änut
tximtmf
tmiohm
iti8u
awajmemtwilw
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DENDAT1415026D
Other languages
German (de)
English (en)
Publication of DE1415026U publication Critical patent/DE1415026U/de
Active legal-status Critical Current

Links

Landscapes

  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DENDAT1415026D Active DE1415026U (enExample)

Publications (1)

Publication Number Publication Date
DE1415026U true DE1415026U (enExample)

Family

ID=725266

Family Applications (1)

Application Number Title Priority Date Filing Date
DENDAT1415026D Active DE1415026U (enExample)

Country Status (1)

Country Link
DE (1) DE1415026U (enExample)

Similar Documents

Publication Publication Date Title
US10668051B2 (en) Modulators of calcium release-activated calcium channel
DE69627035T2 (de) Derivate von aminosäuren, sie enthaltende pharmazeutische zusammensetzungen sowie deren herstellunsgverfahren
ES2817700T3 (es) Derivados de 2-(pirimidin-5-il)-tiopirimidina como moduladores de Hsp70 y Hsc70 para el tratamiento de trastornos proliferativos
US20090170849A1 (en) Quinazolinone derivatives having b-raf inhibitory activity
KR101937704B1 (ko) 2-(2,4,5-치환 아닐린)피리미딘 유도체, 이의 약물 조성물 및 이의 용도
ES2625735T3 (es) Análogos y derivados de GLP-1
US20080275022A1 (en) Substituted Quinazolones as Anti-Cancer Agents
US20050020612A1 (en) 4-Aryliquinazolines and the use thereof as nhe-3 inhibitors
US20080306096A1 (en) Quinazoline Derivatives, Process for Their Preparation and Their Use as Anti-Cancer Agents
KR20110003340A (ko) Ｒａｆ 키나아제 조절제로서의 퀴나졸린 유도체 및 그의 사용방법
US20090149484A1 (en) Quinazolin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them
US20090163525A1 (en) Substituted quinazolines with anti-cancer activity
US20150126563A1 (en) Small molecule inhibitors of the pleckstrin homology domain and methods for using same
Harker et al. β-Peptides with improved affinity for hDM2 and hDMX
NO322569B1 (no) Nye <alfa>-aminosyreforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem
AU2010258027B2 (en) Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof
CA2978184A1 (en) Modified therapeutic agents and compositions thereof
DE1415026U (enExample)
US10745410B2 (en) Substituted [5,6]cyclic-4(3H)-pyrimidinones as anticancer agents
Zhou et al. Design and optimization of hybrid of 2, 4-diaminopyrimidine and arylthiazole scaffold as anticancer cell proliferation and migration agents
US20050113396A1 (en) 2-Guanidino-4-heterocyclylquinazolines
CA2635916A1 (en) Triazoloanilinopyrimidine derivatives for use as antiviral agents
ES2980112T3 (es) Compuestos y su uso para el tratamiento de la deficiencia en alfa1-antitripsina
US8242142B2 (en) Cyclohexylamines, phenylamines and uses thereof
ES2775781T3 (es) Derivados de pirrolidina novedosos